ReviewCancer medicine2026
Advances in Artificial Intelligence-Based Liver-Related Semantic Segmentation Techniques and Applications Using CT Imaging.
Review in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
BACKGROUND AND
aimsArtificial intelligence (AI)-assisted semantic segmentation of liver computed tomography (CT) images has important clinical value in disease assessment, surgical planning, treatment evaluation, and longitudinal monitoring. This review aims to summarize the current clinical applications and recent technical advances in AI-based liver-related semantic segmentation on CT.
methodsThis narrative review synthesizes recent studies on liver organ, tumor, and vascular segmentation, focusing on both clinical applications across different hepatic diseases and technical developments in model architectures, data processing, information fusion, and strategies for improving robustness and generalizability.
resultsAI-based segmentation models, particularly those built on U-Net and hybrid attention/Transformer frameworks, have enabled automated analysis for clinically relevant tasks such as future liver remnant estimation, graft volumetry, chronic liver disease assessment, tumor burden evaluation, prognosis prediction, and vascular-intervention planning. Despite strong performance in liver organ segmentation, challenges remain in small tumor and fine vascular segmentation, as well as in external validation, deployability, and workflow integration.
conclusionsAI-based liver CT segmentation shows strong potential to support precision hepatobiliary imaging and to improve existing clinical workflows. Further progress will depend on improving robustness, reducing computational burden, enhancing performance in fine-structure segmentation, and facilitating real-world clinical deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.